Sunday, December 21, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

AMREP Corporation Reports Sharp Decline in Earnings per Share for Q3 2024

Elaine Mendonca by Elaine Mendonca
March 8, 2024
in Breaking News
0
Investings on laptop and finances
0
SHARES
8
VIEWS
Share on FacebookShare on Twitter

AMREP Corporation disclosed its financial performance for the third quarter of fiscal 2024 on March 8, 2024. The company reported a net income of $92,000, or $0.02 per diluted share, which is a sharp decrease from $16,574,000, or $3.12 per diluted share, in the same quarter of the prior year. For the first nine months of 2024, AMREP recorded a net income of $2,546,000, or $0.48 per diluted share, as opposed to $22,107,000, or $4.17 per diluted share, in the corresponding period of 2023.

The earnings per share for AMREP plummeted significantly, while sales saw a notable increase during the specified time frames.

AXR Stock Performance Review: Potential Positive Momentum Despite Minor Decline

On March 8, 2024, AXR stock had a mixed performance as it closed at $22.50, which was a decrease of $0.34 or 1.49% from the previous market close. However, in after-hours trading, the stock rose by $0.50, indicating some potential positive momentum.

One key indicator of AXR’s performance is that it is currently trading near the top of its 52-week range and above its 200-day simple moving average. This suggests that the stock has been performing well over a longer period of time, which may be a positive sign for investors.

The slight drop in price during regular trading hours could be attributed to various factors such as market volatility, news events, or changes in investor sentiment. However, the increase in after-hours trading could indicate that some investors see potential value in the stock at its current price.

It is important for investors to consider all relevant factors when evaluating a stock’s performance, including technical indicators, market trends, and company fundamentals. While past performance is not indicative of future results, the current price momentum of AXR may be worth monitoring for those interested in the stock.

AXR Stock Performance: Revenue Decline but Net Income Increase – March 8, 2024 Data Analysis

On March 8, 2024, AXR stock experienced mixed performances based on the financial data provided. The total revenue for the company was $48.68 million over the past year, with a significant decrease of 22.09% compared to the previous year. In the second quarter, the total revenue dropped further to $8.85 million, marking a 13.95% decrease from the previous quarter.

Despite the decline in total revenue, AXR managed to increase its net income over the past year. The net income for the company was reported at $21.79 million, showing a notable 37.37% increase compared to the previous year. However, in the second quarter, the net income decreased to $1.11 million, reflecting a 17.68% drop from the previous quarter.

Earnings per share (EPS) also showed a mixed trend for AXR stock. The EPS for the past year was $4.11, indicating an impressive 86.19% increase from the previous year. However, in the second quarter, the EPS decreased to $0.21, marking a 17.92% decline from the previous quarter.

Tags: AXR
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Biotechnology Stock Market Today (1)

Legend Biotech Reports Strong Financial Results for Q4 2023

Business management and administrations

The Power of Intelligent Business Process Management Suites: How Automation is Revolutionizing Organizational Efficiency

Finance_Investment (2)

Analyst Reiterates Buy Rating on FrancoNevada with Adjusted Price Target

Recommended

JD.com Stock

Pivotal Week Ahead for JD.com as Major European Acquisition and EV Launch Converge

2 months ago
Snowflake Stock

Snowflake Faces Investor Confidence Test After Executive’s Rogue Forecast

2 months ago
Fiserv Stock

Fiserv’s Strategic Expansion Meets Legal Scrutiny

3 months ago
Does_Walmart_Take_Google_Pay

Does Walmart Take Google Pay? Exploring Walmart’s Exclusive Payment Solution

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple Applovin ASML BioNTech Bitcoin Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Intellia Therapeutics Faces Mounting Analyst Scrutiny Amid Regulatory Setback

Strategy Inc. Faces a Critical Index Classification Decision

DeFi Technologies Broadens Global Reach with New Listings and Products

Barrick Gold Secures Key Resolution in Mali, Paving Way for Mine Restart

Analyst Upgrade Sends Red Cat Shares Soaring

A Billion-Dollar Vote of Confidence for Standard Lithium

Trending

Tesla Stock
Automotive & E-Mobility

Tesla’s Valuation Faces Crucial Test Amid Legal Victory and Robotaxi Push

by Dieter Jaworski
December 21, 2025
0

Tesla shares are trading near their 52-week high as the company approaches a pivotal week, fueled by...

Wolfspeed Stock

Wolfspeed Secures Financial and Strategic Milestones

December 21, 2025
Textron Stock

Textron Stock Approaches Annual Peak Amid Strategic Wins

December 21, 2025
Intellia Therapeutics Stock

Intellia Therapeutics Faces Mounting Analyst Scrutiny Amid Regulatory Setback

December 21, 2025
Strategy Stock

Strategy Inc. Faces a Critical Index Classification Decision

December 21, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Tesla’s Valuation Faces Crucial Test Amid Legal Victory and Robotaxi Push
  • Wolfspeed Secures Financial and Strategic Milestones
  • Textron Stock Approaches Annual Peak Amid Strategic Wins

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com